Our Mission — Our mission is to improve the treatment of serious orphan diseases through the development of novel, site-specific, inhaled liposomal drug products and protein-based therapeutics, and to efficiently and effectively move our product candidates through the regulatory approval process.
Our Operating Principles — The foundation of the Insmed Operating Principles is our dedication to serving patients while we build shareholder value. At Insmed, patients are our inspiration and serve as our compass when making difficult decisions. At Insmed, we work to build long term shareholder value through the following operating principles:
